|
|
Post by babaoriley on Oct 4, 2017 22:20:07 GMT -5
Curious as to the behavior here.
As you can tell from my wording, I fall into the "sold prudently" category.
|
|
|
|
Post by centralcoastinvestor on Oct 4, 2017 22:50:36 GMT -5
No way am I going to sell. To the moon, or crash and burn for me. No middle of the road.
|
|
|
|
Post by slugworth008 on Oct 4, 2017 23:32:27 GMT -5
After the beating I've (all longs have) taken the past 4 years...I'm with Central. Holding tight and feeling cautiously optimistic.
|
|
|
|
Post by dreamboatcruise on Oct 5, 2017 0:12:44 GMT -5
Had a smattering of Oct weekly calls, so unloaded those while there was still a nice premium... unfortunately earlier than I should have. But very tiny bit of my holdings. I'll likely not sell any substantial amount until into new year at earliest. Though I might consider some out of the money Feb or May puts as hedge.
|
|
|
|
Post by coco on Oct 5, 2017 1:21:03 GMT -5
No way am I going to sell. To the moon, or crash and burn for me. No middle of the road. [b I'm with you. Haven't held this long to sell and see it go up substantially. In for the long haul. |
|
|
|
Post by straightly on Oct 5, 2017 1:49:10 GMT -5
No way am I going to sell. To the moon, or crash and burn for me. No middle of the road. [b I'm with you. Haven't held this long to sell and see it go up substantially. In for the long haul. Watching the sp goes up quickly is surely exciting. But now that we have proofs of Afrezz's superiority and reasons to believe our cash situation has options, our current sp is way below what it should be. |
|
|
|
Post by #NoMoreNeedles on Oct 5, 2017 3:43:41 GMT -5
No Guts, No Glory! ALL IN  |
|
|
|
Post by promann on Oct 5, 2017 3:47:07 GMT -5
Bab. I’m still giddy.. I expect this run is going to continue we have momentum and we are still way under valued.. and I agree with Slug after the beating we have taken and held all this time there is no way Im selling. I’m coming back for vengeance.. I want my money back plus double that before I sell a share. It’s just a matter of time.
|
|
|
|
Post by sportsrancho on Oct 5, 2017 5:25:34 GMT -5
I was ready:-) Did Not add and will not sell. It’s only the beginning...
|
|
|
|
Post by falconquest on Oct 5, 2017 6:23:10 GMT -5
I will be looking for a pull back in the price due to profit taking or if Mike decides to dilute for funding. Once the cash situation is resolved to a degree then I may have more confidence in the share price. To put this in perspective we are sitting at ~$0.71 pre-split. I can't help but play this very conservatively now.
|
|
|
|
Post by joeypotsandpans on Oct 5, 2017 7:18:19 GMT -5
Granted a super small sample size above but with 93% so far either holding or adding, and those who have held and already have their shares lent out and are on a "dividend re-investment plan" with the proceeds, it is pretty evident why the the large short position is trapped now and back when they couldn't get out at the bottom near .13....thus the skew of call to put ratio climbing. I am selling my deep ITM and doubling positions rolling up the ladder further out. As far as my shares, like I said locked them up and lost the key. Are we having fun yet?  |
|
|
|
Post by boytroy88 on Oct 5, 2017 7:18:55 GMT -5
I'm with most of you and standing my ground. Had thought to add a few days ago but chickened out. I did add the last time following Tinkerbell 's great write up after the previous CC so I've average down a bit but still underwater. As they say - Long and Strong! |
|
|
|
Post by compound26 on Oct 5, 2017 7:39:43 GMT -5
Added some Jan. 19 $4 calls to my position.
Won't sell any below $10. May sell a bit at around $10.
Will only sell the majority at $20-25 or above or upon a buy-out.
IMHO, the fair value of MNKD is $20-25 right now, which can be achieved by a peak annual sale of Afrezza at $200 million gross, with $100 million profit and a PE at 20. Mannkind will easily reach this target by just being a niche player in any of the following markets: the pediatric market, PWDs using CGMs/Freestyle Libre/Ond Drop, and PWDs using Afrezza as a supplement to RAAs (just to correct high BGs).
And the above does not even take into account the international market and the other TS applications. So I am in full agreement with Nate in that the fair value for MNKD is a market cap of $1-3 billion right now ($10-30 PPS).
And if Afrezza actually becomes a major player in the diabetes market in general, i.e., successfully grabbing a substantial market share from RAAs, then the sky is the limit. Just think about it, what if tiny little MNKD has a $500 million annual profit? Where will the PPS be at?
|
|
|
|
Post by boca1girl on Oct 5, 2017 7:41:48 GMT -5
I'm with you. Haven't held this long to sell and see it go up substantially. In for the long haul. Watching the sp goes up quickly is surely exciting. But now that we have proofs of Afrezz's superiority and reasons to believe our cash situation has options, our current sp is way below what it should be. I bought more Monday pre-market after the cc at $2.35 and then watched the stock price fall to $2 at the open, just my luck. I will hold tight for the foreseeable future. I worked on the original IBM PC in 1980 and didn’t buy Intel and Microsoft when they came public. That was the biggest mistake of my financial life. I’m not going to shortchange my opportunity with MNKD. I’m looking far beyond Afrezza. The pipeline potential is enormous. I may trim my original shares (cost basis of $35) at year end for tax loss if I need to, but will hold onto the majority of my shares for a very long time. |
|
|
|
Post by jonny80s on Oct 5, 2017 8:07:12 GMT -5
Added modestly....
It would be great to see a bump in scripts tomorrow.
|
|
